Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
7 Strange Devices to Make Your Party Stick Out! - 2Moon milestones: A rundown of Artemis 2's many spaceflight firsts
- 3Step by step instructions to Utilize Open Record Rewards for Your Potential benefit
- 4What is the 'Survivor 50' Challenge? Hidden immunity idols will be up for grabs in every U.S. state.
- 5Scientists uncover an ant assassination scheme that helps a parasitic queen rise to power
- Step by step instructions to Keep up with the Life span of Your Kona SUV's Battery Duration
- Exploring the Gig Economy: Examples from Consultants
- Wisconsin archaeologists identify 16 ancient canoes in a prehistoric lake 'parking lot'
- New portrait of the oldest-known supernova | Space photo of the day for March 27, 2026
- French and Malaysian authorities are investigating Grok for generating sexualized deepfakes
- German mid-sized firms gloomy on outlook, survey finds
- Dark matter obeys gravity after all — could that rule out a 5th fundamental force in the universe?
- Netanyahu leads meeting on West Bank riots, Katz defends axing administrative detention for Jews
- World's oldest known tortoise still very much alive despite rumor to the contrary
